Allergic Conjunctivitis Market to Garner USD 2.95 Billion, Globally, by 2031 at 4.28% CAGR: Allied Market Research

Rise in patient population of allergic conjunctivitis across the globe and rise in demand for healthcare services have boosted the growth of the global allergic conjunctivitis market.

PORTLAND, Ore., Aug. 17, 2022 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Allergic Conjunctivitis Market by Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Others), by Disease Type (Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC)), by Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2021-2031". As per the report, the global allergic conjunctivitis industry was accounted for $1.93 billion in 2021, and is expected to reach $2.95 billion by 2031, growing at a CAGR of 4.28% from 2022 to 2031.

Major determinants of the market growth

Rise in patient population of allergic conjunctivitis across the globe and rise in demand for healthcare services have boosted the growth of the global allergic conjunctivitis market. In addition, increase in focus on major market players on R&D activities to develop drugs for allergic conjunctivitis supplemented the market growth. However, adverse reaction of allergic conjunctivitis medication hinder the market growth. On the contrary, surge in awareness regarding the disease would open new opportunities in the future.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/17481

Covid-19 scenario:

• The Covid-19 pandemic had negatively affected the market due to interruptions experienced by patients for getting treatment for allergic conjunctivitis in healthcare facilities.
• Several clinics and hospitals across the world were restructured to increase the hospital capacity for patients with Covid-19. During the pandemic, the non-essential procedures took a backlog.
• The prolonged lockdown disrupted the supply chain and created interruptions in manufacturing as well as transportation of healthcare essentials.

Get detailed COVID-19 impact analysis on the Allergic Conjunctivitis Market- https://www.alliedmarketresearch.com/request-for-customization/17481?reqfor=covid

The antihistamines & mast cell stabilizers segment dominated the market

By drug class, the antihistamines & mast cell stabilizers segment held the largest share in 2021, accounting for around three-fifths of the global allergic conjunctivitis market, and is projected to continue its dominance during the forecast period. In addition, the segment is estimated to register the highest CAGR of 4.81% during the forecast period, owing to new product launches by various key market players. The report includes analysis of the corticosteroids and others segments.

The seasonal allergic conjunctivitis (SAC) segment to portray the highest CAGR through 2030

By disease type, the seasonal allergic conjunctivitis (SAC) segment is projected to manifest the highest CAGR of 4.66% from 2022 to 2031. In addition, the segment held the largest share in 2021, contributing to nearly two-thirds of the global allergic conjunctivitis market, due to prevalence of seasonal allergic conjunctivitis. The report includes analysis of the perennial allergic conjunctivitis (PAC) segment.

The drug stores & retail pharmacies segment dominated the market

By distribution channel, the drug store & retail pharmacies segment held the largest share in 2021, accounting for around three-fifths of the global allergic conjunctivitis market, and is expected to continue its dominance throughout the forecast period. This is due to its presence in commercial areas of a community. However, the online providers segment is projected to manifest the highest CAGR of 6.23% during the forecast period, due to popular medium for purchase of medicines.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/17481

North America held the lion's share

By region, the global allergic conjunctivitis market across North America dominated the market in terms of revenue in 2021, accounting for more than two-fifths of the market, and is projected to dominate the market during the forecast period. This is due to technological advancements in allergic conjunctivitis treatment, and presence of key and robust hospital infrastructure in the region. However, the market across Asia-Pacific is expected to register the highest CAGR of 5.36% during the forecast period, due to rise in patient population, development of healthcare infrastructure, and increase in investments projects in the region.

Major market players

• AbbVie Inc.
• Ajanta Pharma Limited
• Akron Operating Company LLC
• Alembic Pharmaceuticals Ltd
• Bausch Health Companies Inc.
• Cipla, Inc.
• Grevis Pharmaceutical Private Limited
• Indoco Remedies Ltd.
• Jabs Biotech Pvt. Ltd.
• JAWA Pharmaceuticals Pvt. Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Novartis AG
• Santen Pharmaceuticals Co. Ltd.
• Spectra Vision Care Pvt. Ltd.
• Sun Pharmaceuticals Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

The report analyzes these key players of the global allergic conjunctivitis market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.

Official Press Release- Official Press Release- https://www.alliedmarketresearch.com/press-release/allergic-conjunctivitis-market.html

Similar Research Reports for Information, Communication and Technology:

Synthetic Biology Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Remote Patient Monitoring Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Molecular Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Neuroprosthetics Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact: 
David Correa 
5933 NE Win Sivers Drive 
#205, Portland, OR 97220 
United States 
Toll Free: +1-800-792-5285 
UK: +44-845-528-1300 
Hong Kong: +852-301-84916 
India (Pune): +91-20-66346060 
Fax: +1-855-550-5975 
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg